FN2 Earnings Intelligence
Johnson & Johnson financials
Johnson & Johnson (JNJ) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 1/2/2022 | 1/1/2023 | 12/31/2023 | 12/29/2024 | 12/28/2025 | 12/28/2026 est. | 12/28/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $14,487 | $14,127 | $21,859 | $24,105 | $19,709 | - | - |
| + Debt | $33,751 | $39,659 | $29,332 | $36,634 | $47,933 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $93,775 | $94,943 | $85,159 | $88,821 | $94,193 | $101,278.3 | $108,833.8 |
| % Growth | 13.6% | 1.2% | -10.3% | 4.3% | 6.0% | 7.5% | 7.5% |
| Gross Profit | $63,920 | $63,854 | $58,606 | $61,350 | $63,937 | - | - |
| % Margin | 68.2% | 67.3% | 68.8% | 69.1% | 67.9% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $20,878 | $17,941 | $35,153 | $14,066 | $26,804 | - | - |
| % Margin | 22.3% | 18.9% | 41.3% | 15.8% | 28.5% | - | - |
| Diluted EPS | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 | $11.53 | $12.73 |
| % Growth | 41.7% | -13.8% | 103.9% | -57.8% | 90.5% | 4.5% | 10.4% |
| Operating Cash Flow | $23,410 | $21,194 | $22,791 | $24,266 | $24,530 | - | - |
| CapEx | $3,652 | $4,009 | $4,543 | $4,424 | $4,832 | - | - |
| Free Cash Flow | $19,758 | $17,185 | $18,248 | $19,842 | $19,698 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 1/2/2022 | 1/1/2023 | 12/31/2023 | 12/29/2024 | 12/28/2025 | 12/28/2026 est. | 12/28/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $93,775 | $94,943 | $85,159 | $88,821 | $94,193 | $101,278.3 | $108,833.8 |
| Gross Profit | $63,920 | $63,854 | $58,606 | $61,350 | $63,937 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $20,878 | $17,941 | $35,153 | $14,066 | $26,804 | - | - |
| Diluted EPS | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 | $11.53 | $12.73 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 1/2/2022 | 1/1/2023 | 12/31/2023 | 12/29/2024 | 12/28/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $14,487 | $14,127 | $21,859 | $24,105 | $19,709 |
| Short-term Debt | $3,766 | $12,771 | $3,451 | $5,983 | $8,495 |
| Long-term Debt | $29,985 | $26,888 | $25,881 | $30,651 | $39,438 |
| Total Debt | $33,751 | $39,659 | $29,332 | $36,634 | $47,933 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 1/2/2022 | 1/1/2023 | 12/31/2023 | 12/29/2024 | 12/28/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $23,410 | $21,194 | $22,791 | $24,266 | $24,530 |
| Capital Expenditure | $3,652 | $4,009 | $4,543 | $4,424 | $4,832 |
| Free Cash Flow | $19,758 | $17,185 | $18,248 | $19,842 | $19,698 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 1/2/2022 | 1/1/2023 | 12/31/2023 | 12/29/2024 | 12/28/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 13.6% | 1.2% | -10.3% | 4.3% | 6.0% |
| Gross Margin | 68.2% | 67.3% | 68.8% | 69.1% | 67.9% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 22.3% | 18.9% | 41.3% | 15.8% | 28.5% |
| FCF Margin | 21.1% | 18.1% | 21.4% | 22.3% | 20.9% |
| Diluted EPS Growth | 41.7% | -13.8% | 103.9% | -57.8% | 90.5% |
Get the JNJ recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.